Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

Masahiro Fujita, Scott W. Woods, N. Paul L.G. Verhoeff, Anissa Abi-Dargham, Ronald M. Baldwin, Sami S. Zoghbi, Jair C. Soares, Peter A. Jatlow, John H. Krystal, Nallakkandi Rajeevan, Dennis S. Charney, John P. Seibyl, Robert B. Innis

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

Changes of central type GABA(A)/benzodiazepine receptors during 24-day per-oral administration of alprazolam (2 mg/day) were measured with single photon emission computed tomography (SPECT) in nine healthy human subjects. Receptor densities were measured on days -4 (baseline), 3, 10, 17 and 24. Comparison of baseline and day 3 SPECT images was used to assess receptor occupancy; comparisons of the four scans on medication were used to assess alterations in receptor levels. Clinical effects were evaluated by subjective ratings of mood and the Hopkins verbal learning test. Alprazolam induced sedation associated with a 16% receptor occupancy. Unoccupied receptor levels decreased 10% from day 3 to day 10 but then normalized to baseline values by day 17. Clinical effects showed corresponding changes 1-2 weeks after the changes in the receptor. Thus, the decrease of benzodiazepine receptor densities may be one of the major mechanisms for tolerance development in humans. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)161-172
Number of pages12
JournalEuropean Journal of Pharmacology
Volume368
Issue number2-3
DOIs
StatePublished - Mar 5 1999

Keywords

  • Benzodiazepine
  • Down regulation
  • GABA(A)/benzodiazepine receptor
  • Human
  • SPECT (single photon emission computed tomography)

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans'. Together they form a unique fingerprint.

Cite this